EA200400954A1 - Фармацевтическая композиция, содержащая 2,2-дихлор-12-(4-хлорфенил)додекановую кислоту - Google Patents

Фармацевтическая композиция, содержащая 2,2-дихлор-12-(4-хлорфенил)додекановую кислоту

Info

Publication number
EA200400954A1
EA200400954A1 EA200400954A EA200400954A EA200400954A1 EA 200400954 A1 EA200400954 A1 EA 200400954A1 EA 200400954 A EA200400954 A EA 200400954A EA 200400954 A EA200400954 A EA 200400954A EA 200400954 A1 EA200400954 A1 EA 200400954A1
Authority
EA
Eurasian Patent Office
Prior art keywords
chlorophenyl
pharmaceutical composition
acid
dedecanic
dichlor
Prior art date
Application number
EA200400954A
Other languages
English (en)
Other versions
EA007650B1 (ru
Inventor
Син-итиро Кобаяси
Нийтиро Такано
Хироюки Кавасима
Ясуо Синода
Тосио Инаги
Original Assignee
Кова Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кова Ко., Лтд. filed Critical Кова Ко., Лтд.
Publication of EA200400954A1 publication Critical patent/EA200400954A1/ru
Publication of EA007650B1 publication Critical patent/EA007650B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Abstract

Высокостабильная фармацевтическая композиция, которая включает смесь, содержащую вещество, выбранное из группы, состоящей из 2,2-дихлор-12-(4-хлорфенил)додекановой кислоты, ее солей и ее сложных эфиров, и кроскармеллозу натрия.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200400954A 2002-01-16 2003-01-15 Фармацевтическая композиция, содержащая 2,2-дихлор-12-(4-хлорфенил)додекановую кислоту EA007650B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002007022 2002-01-16
PCT/JP2003/000251 WO2003059337A1 (en) 2002-01-16 2003-01-15 Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid

Publications (2)

Publication Number Publication Date
EA200400954A1 true EA200400954A1 (ru) 2004-12-30
EA007650B1 EA007650B1 (ru) 2006-12-29

Family

ID=19191302

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400954A EA007650B1 (ru) 2002-01-16 2003-01-15 Фармацевтическая композиция, содержащая 2,2-дихлор-12-(4-хлорфенил)додекановую кислоту

Country Status (20)

Country Link
US (1) US20060051410A1 (ru)
EP (1) EP1473033A1 (ru)
JP (1) JPWO2003059337A1 (ru)
KR (1) KR20040090975A (ru)
CN (1) CN1259909C (ru)
AU (1) AU2003201879B2 (ru)
BR (1) BR0307172A (ru)
CA (1) CA2474014A1 (ru)
EA (1) EA007650B1 (ru)
HR (1) HRP20040718A2 (ru)
IL (1) IL162880A0 (ru)
IS (1) IS7340A (ru)
MX (1) MXPA04006977A (ru)
NO (1) NO20043376L (ru)
NZ (1) NZ534471A (ru)
PL (1) PL373035A1 (ru)
TW (1) TWI252755B (ru)
UA (1) UA80270C2 (ru)
WO (1) WO2003059337A1 (ru)
ZA (1) ZA200406453B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1627866B1 (en) * 2003-05-23 2008-12-24 Kowa Company Ltd. Carboxylic acid compound and medicine containing the same
EP1752145A1 (en) * 2004-06-01 2007-02-14 Kowa Company Ltd. Therapeutic agent for hyperlipemia and therapeutic agent for diabetes
WO2006011397A1 (ja) * 2004-07-27 2006-02-02 Kowa Company., Ltd. 糖尿病の予防または治療のための薬剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
CA2100836C (en) * 1993-07-19 1998-02-03 Bernard Charles Sherman PHARMACEUTICAL COMPOSITION
DE4439947A1 (de) * 1994-11-09 1996-05-15 Boehringer Mannheim Gmbh 2,2-Dichloralkancarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
UY26615A1 (es) * 2000-03-16 2001-10-25 Pfizer Prod Inc Inhibidor de la glucogeno fosforilasa.

Also Published As

Publication number Publication date
BR0307172A (pt) 2004-11-03
WO2003059337A1 (en) 2003-07-24
PL373035A1 (en) 2005-08-08
TWI252755B (en) 2006-04-11
US20060051410A1 (en) 2006-03-09
UA80270C2 (en) 2007-09-10
CN1612730A (zh) 2005-05-04
EA007650B1 (ru) 2006-12-29
ZA200406453B (en) 2006-06-28
IS7340A (is) 2004-06-30
NZ534471A (en) 2005-08-26
TW200302079A (en) 2003-08-01
NO20043376L (no) 2004-08-13
CA2474014A1 (en) 2003-07-24
AU2003201879B2 (en) 2007-09-13
KR20040090975A (ko) 2004-10-27
MXPA04006977A (es) 2005-04-19
EP1473033A1 (en) 2004-11-03
JPWO2003059337A1 (ja) 2005-05-19
AU2003201879A1 (en) 2003-07-30
IL162880A0 (en) 2005-11-20
CN1259909C (zh) 2006-06-21
HRP20040718A2 (en) 2004-12-31

Similar Documents

Publication Publication Date Title
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
EA200300873A1 (ru) Новая соль сукцинат o-десметилвенлафаксина
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
SE8700499D0 (sv) Novel pharmacologically active compounds
IS4326A (is) Ný forðakyrni og lyfjablanda sem inniheldur þau
BR0109943A (pt) Composições farmacêuticas
EA200300050A1 (ru) Гликопептидфосфонатные производные
CO5580776A2 (es) Formulacion farmaceutica estable en solucion de oxaliplatino
EA200500891A1 (ru) Фармацевтические композиции, содержащие щелочные или соответственно кислые лекарственные соединения, поверхностно-активное вещество и физиологически приемлемую водорастворимую кислоту или соответственно основание
NO965012D0 (no) Farmasöytisk preparat som omfatter glukagon
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
BRPI0417684A (pt) composto, composição farmacêutica, e, uso de um composto
RS20050066A (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
RU2695274C3 (ru) Новые композиции и способы их стабилизации
EA200001039A1 (ru) Кальцилитические соединения
EA200200831A1 (ru) Фармацевтическая композиция, включающая пеметрексед вместе с монотиоглицерином, l-цистеином или тиогликолевой кислотой
EA200400819A1 (ru) Парентеральная композиция парацетамола
EA199901116A1 (ru) Композиция, включающая 5-[4-[2-(n-метил-n-2-пиридил)-амино)этокси]бензил]тиазолидин-2,4-дион
BR9912706A (pt) Composições farmacêuticas contendo ibuprofeno e domperidona
EA200100984A1 (ru) Новые кристаллические формы макролидного антибиотика
EA200400707A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
EA200400954A1 (ru) Фармацевтическая композиция, содержащая 2,2-дихлор-12-(4-хлорфенил)додекановую кислоту
EA199700223A1 (ru) Бициклические антагонисты тахикининов, их получение и применение в фармацевтической композиции
DE69827614D1 (de) Chinoxalindionen
ATE263547T1 (de) Pharmazeutische mischung, die ein profen und weitere aktivsubstanzen enthält

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU